INDIANAPOLIS, Oct. 30 /PRNewswire-FirstCall/ -- On Sunday, November 4, 2007, Eli Lilly and Company will conduct a conference call with the investment community and media to review the details of prasugrel scientific data being presented at the American Heart Association Scientific Sessions in Orlando, Florida. This call will follow the TIMI Study Group's presentation of initial results of the TRITON TIMI-38 trial.
The Lilly conference call will be held from 4:30 p.m. to 5:30 p.m. EST. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at http://www.lilly.com/. The webcast of the conference call will be available for replay through November 19, 2007.
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com/. P-LLY
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk,
